SlideShare ist ein Scribd-Unternehmen logo
1 von 15
‫الرحيم‬ ‫الرحمن‬ ‫اللة‬ ‫بسم‬‫الرحيم‬ ‫الرحمن‬ ‫اللة‬ ‫بسم‬
Tumor immunologyTumor immunology
Tumor immunologyTumor immunology
** Pathological cell massesPathological cell masses derived by abnormal andderived by abnormal and
uncontrollable clonal expansion of single celluncontrollable clonal expansion of single cell
* Transformation of normal cells to malignant cells by:* Transformation of normal cells to malignant cells by:
a-a- Spontaneous mutationSpontaneous mutation during daily cell divisionduring daily cell division
chemical carcinogenschemical carcinogens
b- It may beb- It may be induced byinduced by physical carcinogensphysical carcinogens
virusesviruses
* Cells become* Cells become antigenically differentantigenically different from normal cellsfrom normal cells
* They are* They are recognizedrecognized andand destroyeddestroyed byby immune systemimmune system
Etiology Of TumorEtiology Of Tumor
1) Inherited :1) Inherited :
Expression of inherited oncogeneExpression of inherited oncogene
e.g. viral gene incorporated into host genee.g. viral gene incorporated into host gene
2) Viral:2) Viral:
- Human papilloma, herpes type 2, HBV, EBV (DNA)- Human papilloma, herpes type 2, HBV, EBV (DNA)
- Human T-cell leuckemia virus (RNA)- Human T-cell leuckemia virus (RNA)
3) Chemical:3) Chemical:
- Poly cyclic hydrocarbons cause sarcomas- Poly cyclic hydrocarbons cause sarcomas
- Aromatic amines cause mammary carcinoma- Aromatic amines cause mammary carcinoma
- Alkyl nitroso amines cause hepatoma- Alkyl nitroso amines cause hepatoma
4) Radiological:4) Radiological: Ultraviolet & ionizing irradiationUltraviolet & ionizing irradiation
5) Spontaneous:5) Spontaneous: failure in the cellular growth controlfailure in the cellular growth control
Tumor Associated AntigensTumor Associated Antigens
!) Viral Antigen :!) Viral Antigen :
a- Viral proteins and glycoproteinsa- Viral proteins and glycoproteins
b- New antigens produced by virally infected hostb- New antigens produced by virally infected host
cells under control of viral nucleic acidcells under control of viral nucleic acid
2) Tumor specific antigens :2) Tumor specific antigens :
- Tumor cells develop new antigen specific to- Tumor cells develop new antigen specific to
their carcinogenstheir carcinogens
3) Tumor specific transplantation antigens :3) Tumor specific transplantation antigens :
- Tumor cells express new MHC antigens due to- Tumor cells express new MHC antigens due to
alteration of normally present MHC antigensalteration of normally present MHC antigens
Tumor Associated AntigensTumor Associated Antigens
4) Oncofetal antigens:4) Oncofetal antigens:
a- Carcino-embryonic antigens (CEA)a- Carcino-embryonic antigens (CEA)
- Normally expressed during fetal life on fetal gut- Normally expressed during fetal life on fetal gut
- Reappearance in adult life:- Reappearance in adult life:
GIT, pancreas, biliary system and cancer breastGIT, pancreas, biliary system and cancer breast
b- Alpha fetoprotein:b- Alpha fetoprotein:
- Normally expressed in fetal life- Normally expressed in fetal life
- Reappearance in adult life; hepatoma- Reappearance in adult life; hepatoma
Immune Surveillance SystemImmune Surveillance System
* During neoplastic transformation, new antigen develop* During neoplastic transformation, new antigen develop
* The host recognize them as nonself antigens* The host recognize them as nonself antigens
* Cell mediated immune reactions attack these* Cell mediated immune reactions attack these
nonself tumor cellsnonself tumor cells
* Immune response act as surveillance system* Immune response act as surveillance system
to detect and eliminate newly arising neoplastic cellsto detect and eliminate newly arising neoplastic cells
Immune Surveillance SystemImmune Surveillance System
This system include :This system include :
1) Natural killer (NK) cells1) Natural killer (NK) cells
They kill directly tumor cells,helped by interferon, IL-2They kill directly tumor cells,helped by interferon, IL-2
2) Cytotoxic T-cells2) Cytotoxic T-cells
They also kill directly tumor cellsThey also kill directly tumor cells
3) Cell mediated T-cells (effector T-cells)3) Cell mediated T-cells (effector T-cells)
They produce and release a variety of lymphokines :They produce and release a variety of lymphokines :
a-Macrophage activation factora-Macrophage activation factor that activate macrophagthat activate macrophag
b-Gamma interferon and interleukin-2b-Gamma interferon and interleukin-2 that activate NKthat activate NK
c-Tumor necrosis factor (cachectine)c-Tumor necrosis factor (cachectine)
Immune Surveillance SystemImmune Surveillance System
4) B-cells :4) B-cells :
- Tumor associated antigens stimulate production of- Tumor associated antigens stimulate production of
specific antibodies by host B-cellsspecific antibodies by host B-cells
- These specific antibodies bind together on tumor cell surface- These specific antibodies bind together on tumor cell surface
leading to destruction of tumor through:leading to destruction of tumor through:
a- Antibody mediated-cytotoxicity :a- Antibody mediated-cytotoxicity :
killkill
Cytotoxic T-cells IgG-coated tumor cellsCytotoxic T-cells IgG-coated tumor cells
b- Activation of macrophagesb- Activation of macrophages
releaserelease
Sensitized T-cells macrophage activating factorSensitized T-cells macrophage activating factor
IgG-coated tumor cells macrophagesIgG-coated tumor cells macrophages
activateactivate
c- Activation of classical pathway of complementc- Activation of classical pathway of complement leading toleading to
Tumor EscapeTumor Escape
Mechanisms by which tumor escape immune defenses:Mechanisms by which tumor escape immune defenses:
1) Reduced levels or absence of MHCI molecule1) Reduced levels or absence of MHCI molecule onon
tumor so that they can not be recognized by CTLstumor so that they can not be recognized by CTLs
2) Some tumors stop expressing the antigens2) Some tumors stop expressing the antigens
These tumors are called “antigen loss variants”These tumors are called “antigen loss variants”
3) Production of immunosuppressive factors by tumor3) Production of immunosuppressive factors by tumor
e.g. transforming growth factor (TGF-e.g. transforming growth factor (TGF-ββ))
4) Tumor antigens may induce specific immunologic4) Tumor antigens may induce specific immunologic
tolerancetolerance
Tumor EscapeTumor Escape
5) Tumor cells have an inherent defect in antigen5) Tumor cells have an inherent defect in antigen
processing and presentationprocessing and presentation
6) Blocking of receptors on T-cells by specific antigen6) Blocking of receptors on T-cells by specific antigen
antibodies complex (antibodies complex (after shedding of tumor Ag)after shedding of tumor Ag)
prevents them from recognizing and attackingprevents them from recognizing and attacking
tumor cellstumor cells
7) Antigens on the surface of tumors may be masked7) Antigens on the surface of tumors may be masked
by sialic acid-containing mucopolysaccharidesby sialic acid-containing mucopolysaccharides
8) Immune suppression of the host as in transplant8) Immune suppression of the host as in transplant
patientspatients who show a higher incidence of malignancywho show a higher incidence of malignancy
Tumor MarkersTumor Markers
* Tumor markers :* Tumor markers :
Tumor antigensTumor antigens
* They are either or* They are either or
Tumor productsTumor products
(enzymes and hormones)(enzymes and hormones)
* Tumor products are released in the serum of patients* Tumor products are released in the serum of patients
* They are used to* They are used to confirm diagnosisconfirm diagnosis andand follow upfollow up thethe
response toresponse to therapytherapy
Tumor AntigensTumor Antigens
1) Alpha fetoprotein antigen (AFP)1) Alpha fetoprotein antigen (AFP) in cases of hepatomain cases of hepatoma
2) Carcinoembryoinic antigen (CEA)2) Carcinoembryoinic antigen (CEA) in gastrointestinalin gastrointestinal
tumors, tumors of biliary system and cancer breasttumors, tumors of biliary system and cancer breast
3) Cancer antigen 1253) Cancer antigen 125 (CA 125)(CA 125) in ovarian carcinomain ovarian carcinoma
4) Cancer antigen 15-3 (CA15-3)4) Cancer antigen 15-3 (CA15-3) in breast cancerin breast cancer
5) Cancer antigen 19-95) Cancer antigen 19-9 in colon and pancreatic tumorin colon and pancreatic tumor
6) Prostatic specific antigen (PSA)6) Prostatic specific antigen (PSA) in prostatic tumorsin prostatic tumors
Tumor ProductsTumor Products
a) Hormones :a) Hormones :
-- Human chorionic gonadotrophins (HCG)Human chorionic gonadotrophins (HCG) are secretedare secreted
in cases of choriocarcinomain cases of choriocarcinoma
- Thyroxin (T3 & T4)- Thyroxin (T3 & T4) is secreted in cases of canceris secreted in cases of cancer
of thyroid glandof thyroid gland
b) Enzymes :b) Enzymes :
- Acid phosphatase- Acid phosphatase enzymes in cases of cancer prostaeenzymes in cases of cancer prostae
- Alkaline phosphatese, lipase and amylase- Alkaline phosphatese, lipase and amylase enzymes inenzymes in
cases of cancer pancreascases of cancer pancreas
ThanksThanks

Weitere ähnliche Inhalte

Was ist angesagt? (20)

Iimmunity to tumors
Iimmunity to tumorsIimmunity to tumors
Iimmunity to tumors
 
Tumourclasss
TumourclasssTumourclasss
Tumourclasss
 
Tumor immunology by nidhi
Tumor immunology by nidhiTumor immunology by nidhi
Tumor immunology by nidhi
 
Cancer and the Immune System
Cancer and the Immune SystemCancer and the Immune System
Cancer and the Immune System
 
Advanced tumor immunology prof dr.ihsan edan alsaimary university of basrah...
Advanced tumor immunology prof dr.ihsan edan alsaimary   university of basrah...Advanced tumor immunology prof dr.ihsan edan alsaimary   university of basrah...
Advanced tumor immunology prof dr.ihsan edan alsaimary university of basrah...
 
Cancer Immuno editing
Cancer Immuno editingCancer Immuno editing
Cancer Immuno editing
 
Tumour immunology
Tumour immunologyTumour immunology
Tumour immunology
 
Ch 18 tumor immunology
Ch 18 tumor immunologyCh 18 tumor immunology
Ch 18 tumor immunology
 
Tumour immunology
Tumour immunologyTumour immunology
Tumour immunology
 
CANCER IMMUNOLOGY- TERMINOLOGIES
CANCER IMMUNOLOGY- TERMINOLOGIESCANCER IMMUNOLOGY- TERMINOLOGIES
CANCER IMMUNOLOGY- TERMINOLOGIES
 
Tumour immunology
Tumour immunologyTumour immunology
Tumour immunology
 
Immunology and cancer
Immunology and cancerImmunology and cancer
Immunology and cancer
 
Chapter 17 immunotherapy
Chapter 17 immunotherapyChapter 17 immunotherapy
Chapter 17 immunotherapy
 
tumor immunity
tumor immunitytumor immunity
tumor immunity
 
Tumor Immunology presentation by Sharmista
Tumor Immunology presentation by SharmistaTumor Immunology presentation by Sharmista
Tumor Immunology presentation by Sharmista
 
cancer de mama
cancer de mamacancer de mama
cancer de mama
 
IMMUNE RESPONSE TO TUMORS
IMMUNE RESPONSE TO TUMORSIMMUNE RESPONSE TO TUMORS
IMMUNE RESPONSE TO TUMORS
 
Cancer immunology
Cancer immunologyCancer immunology
Cancer immunology
 
Immunosurveillance
ImmunosurveillanceImmunosurveillance
Immunosurveillance
 
Cancer and immune system
Cancer and immune systemCancer and immune system
Cancer and immune system
 

Andere mochten auch

neoplastic disruptions alterations in cell function & differentiation pp
neoplastic disruptions   alterations in cell function & differentiation ppneoplastic disruptions   alterations in cell function & differentiation pp
neoplastic disruptions alterations in cell function & differentiation pptwiggypiggy
 
Mayoz ve mitozun moleküler temelleri
Mayoz ve mitozun moleküler temelleriMayoz ve mitozun moleküler temelleri
Mayoz ve mitozun moleküler temelleriayşen yıldırım
 
Epithelial tumor markers
Epithelial tumor markersEpithelial tumor markers
Epithelial tumor markersvarun surya
 
SERUM TUMOR MARKERS
SERUM TUMOR MARKERSSERUM TUMOR MARKERS
SERUM TUMOR MARKERSPankaj Gupta
 
Tumor immunology
Tumor immunologyTumor immunology
Tumor immunologyPashon Hana
 
Structure Based Drug Design
Structure Based Drug DesignStructure Based Drug Design
Structure Based Drug Designnmicaelo
 
Molecular targeted therapies 2
Molecular targeted therapies 2Molecular targeted therapies 2
Molecular targeted therapies 2Dr Ankur Shah
 
Structure based drug design
Structure based drug designStructure based drug design
Structure based drug designADAM S
 
The human genome project
The human genome projectThe human genome project
The human genome project14pascba
 
Newer Tumour Markers
Newer Tumour MarkersNewer Tumour Markers
Newer Tumour MarkersBina Gadhiya
 
Drug discovery and development
Drug discovery and developmentDrug discovery and development
Drug discovery and developmentrahul_pharma
 

Andere mochten auch (20)

Cancer and immunology
Cancer and immunologyCancer and immunology
Cancer and immunology
 
Tumor immunity
Tumor immunityTumor immunity
Tumor immunity
 
neoplastic disruptions alterations in cell function & differentiation pp
neoplastic disruptions   alterations in cell function & differentiation ppneoplastic disruptions   alterations in cell function & differentiation pp
neoplastic disruptions alterations in cell function & differentiation pp
 
Prostat Kanseri
Prostat KanseriProstat Kanseri
Prostat Kanseri
 
Mayoz ve mitozun moleküler temelleri
Mayoz ve mitozun moleküler temelleriMayoz ve mitozun moleküler temelleri
Mayoz ve mitozun moleküler temelleri
 
SERVİKS KANSERİ VE KORUNMA
SERVİKS KANSERİ VE KORUNMASERVİKS KANSERİ VE KORUNMA
SERVİKS KANSERİ VE KORUNMA
 
Epithelial tumor markers
Epithelial tumor markersEpithelial tumor markers
Epithelial tumor markers
 
SERUM TUMOR MARKERS
SERUM TUMOR MARKERSSERUM TUMOR MARKERS
SERUM TUMOR MARKERS
 
Tumor Immunology
Tumor ImmunologyTumor Immunology
Tumor Immunology
 
Tumor immunology
Tumor immunologyTumor immunology
Tumor immunology
 
Structure Based Drug Design
Structure Based Drug DesignStructure Based Drug Design
Structure Based Drug Design
 
Molecular targeted therapies 2
Molecular targeted therapies 2Molecular targeted therapies 2
Molecular targeted therapies 2
 
Tumor markers
Tumor markersTumor markers
Tumor markers
 
Tumor Marker
Tumor MarkerTumor Marker
Tumor Marker
 
Structure based drug design
Structure based drug designStructure based drug design
Structure based drug design
 
The human genome project
The human genome projectThe human genome project
The human genome project
 
MICROARRAY
MICROARRAYMICROARRAY
MICROARRAY
 
Proteomics ppt
Proteomics pptProteomics ppt
Proteomics ppt
 
Newer Tumour Markers
Newer Tumour MarkersNewer Tumour Markers
Newer Tumour Markers
 
Drug discovery and development
Drug discovery and developmentDrug discovery and development
Drug discovery and development
 

Ähnlich wie ppt 1

11. tumour immunology.pptx
11. tumour immunology.pptx11. tumour immunology.pptx
11. tumour immunology.pptxnedalalazzwy
 
Tumor antigens & cancer immunotherapy.pptx
Tumor antigens & cancer immunotherapy.pptxTumor antigens & cancer immunotherapy.pptx
Tumor antigens & cancer immunotherapy.pptxRagavi32
 
HYBRIDOMA_TECHNOLOGY_and_ITS_APPLICATION.pptx
HYBRIDOMA_TECHNOLOGY_and_ITS_APPLICATION.pptxHYBRIDOMA_TECHNOLOGY_and_ITS_APPLICATION.pptx
HYBRIDOMA_TECHNOLOGY_and_ITS_APPLICATION.pptxSwati Gaikwad
 
TUMOUR IMMUNOLOGY, CLINICAL ASPECTS OF NEOPLASIA & Clinical Features of Tumors
TUMOUR IMMUNOLOGY, CLINICAL ASPECTS OF NEOPLASIA & Clinical Features of TumorsTUMOUR IMMUNOLOGY, CLINICAL ASPECTS OF NEOPLASIA & Clinical Features of Tumors
TUMOUR IMMUNOLOGY, CLINICAL ASPECTS OF NEOPLASIA & Clinical Features of TumorsDr. Roopam Jain
 
tumor immunology.pptx
tumor immunology.pptxtumor immunology.pptx
tumor immunology.pptxAnnie Annie
 
TUMOR IMMUNOLOGY.ppt
TUMOR IMMUNOLOGY.pptTUMOR IMMUNOLOGY.ppt
TUMOR IMMUNOLOGY.pptUmaShanksr
 
Cancer immunology.pptx
Cancer immunology.pptxCancer immunology.pptx
Cancer immunology.pptxAnnie Annie
 
Mariano Barbacid-El cáncer como consecuencia del envejecimiento
Mariano Barbacid-El cáncer como consecuencia del envejecimientoMariano Barbacid-El cáncer como consecuencia del envejecimiento
Mariano Barbacid-El cáncer como consecuencia del envejecimientoFundación Ramón Areces
 
Pharm immuno14&15 cancer & transplantpor
Pharm immuno14&15 cancer & transplantporPharm immuno14&15 cancer & transplantpor
Pharm immuno14&15 cancer & transplantpormmoney1
 
MSI 825Tumor Immunology (1).pptx
MSI 825Tumor Immunology (1).pptxMSI 825Tumor Immunology (1).pptx
MSI 825Tumor Immunology (1).pptxLilianNkinda
 
Cancer Vaccines and Oncolytic Viruses
Cancer Vaccines and Oncolytic VirusesCancer Vaccines and Oncolytic Viruses
Cancer Vaccines and Oncolytic VirusesFathallah Ezzat
 
Ppt30 sak 23.11.17
Ppt30 sak 23.11.17Ppt30 sak 23.11.17
Ppt30 sak 23.11.17sathish sak
 

Ähnlich wie ppt 1 (20)

11. tumour immunology.pptx
11. tumour immunology.pptx11. tumour immunology.pptx
11. tumour immunology.pptx
 
Tumor antigens & cancer immunotherapy.pptx
Tumor antigens & cancer immunotherapy.pptxTumor antigens & cancer immunotherapy.pptx
Tumor antigens & cancer immunotherapy.pptx
 
HYBRIDOMA_TECHNOLOGY_and_ITS_APPLICATION.pptx
HYBRIDOMA_TECHNOLOGY_and_ITS_APPLICATION.pptxHYBRIDOMA_TECHNOLOGY_and_ITS_APPLICATION.pptx
HYBRIDOMA_TECHNOLOGY_and_ITS_APPLICATION.pptx
 
TUMOUR IMMUNOLOGY, CLINICAL ASPECTS OF NEOPLASIA & Clinical Features of Tumors
TUMOUR IMMUNOLOGY, CLINICAL ASPECTS OF NEOPLASIA & Clinical Features of TumorsTUMOUR IMMUNOLOGY, CLINICAL ASPECTS OF NEOPLASIA & Clinical Features of Tumors
TUMOUR IMMUNOLOGY, CLINICAL ASPECTS OF NEOPLASIA & Clinical Features of Tumors
 
tumor immunology.pptx
tumor immunology.pptxtumor immunology.pptx
tumor immunology.pptx
 
TUMOR IMMUNOLOGY.ppt
TUMOR IMMUNOLOGY.pptTUMOR IMMUNOLOGY.ppt
TUMOR IMMUNOLOGY.ppt
 
tumor immunology.pptx
tumor immunology.pptxtumor immunology.pptx
tumor immunology.pptx
 
Cancer immunology.pptx
Cancer immunology.pptxCancer immunology.pptx
Cancer immunology.pptx
 
Ashwani
AshwaniAshwani
Ashwani
 
Mariano Barbacid-El cáncer como consecuencia del envejecimiento
Mariano Barbacid-El cáncer como consecuencia del envejecimientoMariano Barbacid-El cáncer como consecuencia del envejecimiento
Mariano Barbacid-El cáncer como consecuencia del envejecimiento
 
Pharm immuno14&15 cancer & transplantpor
Pharm immuno14&15 cancer & transplantporPharm immuno14&15 cancer & transplantpor
Pharm immuno14&15 cancer & transplantpor
 
Monoclonal antibody
Monoclonal antibodyMonoclonal antibody
Monoclonal antibody
 
MSI 825Tumor Immunology (1).pptx
MSI 825Tumor Immunology (1).pptxMSI 825Tumor Immunology (1).pptx
MSI 825Tumor Immunology (1).pptx
 
Tumor immunology
Tumor immunologyTumor immunology
Tumor immunology
 
Innate immunity
Innate immunityInnate immunity
Innate immunity
 
Cancer Vaccines and Oncolytic Viruses
Cancer Vaccines and Oncolytic VirusesCancer Vaccines and Oncolytic Viruses
Cancer Vaccines and Oncolytic Viruses
 
Tumor antigen
Tumor antigenTumor antigen
Tumor antigen
 
Ppt30 sak 23.11.17
Ppt30 sak 23.11.17Ppt30 sak 23.11.17
Ppt30 sak 23.11.17
 
Host tumor.pptx
Host tumor.pptxHost tumor.pptx
Host tumor.pptx
 
mono clonals.pptx
mono clonals.pptxmono clonals.pptx
mono clonals.pptx
 

ppt 1

  • 1. ‫الرحيم‬ ‫الرحمن‬ ‫اللة‬ ‫بسم‬‫الرحيم‬ ‫الرحمن‬ ‫اللة‬ ‫بسم‬
  • 3. Tumor immunologyTumor immunology ** Pathological cell massesPathological cell masses derived by abnormal andderived by abnormal and uncontrollable clonal expansion of single celluncontrollable clonal expansion of single cell * Transformation of normal cells to malignant cells by:* Transformation of normal cells to malignant cells by: a-a- Spontaneous mutationSpontaneous mutation during daily cell divisionduring daily cell division chemical carcinogenschemical carcinogens b- It may beb- It may be induced byinduced by physical carcinogensphysical carcinogens virusesviruses * Cells become* Cells become antigenically differentantigenically different from normal cellsfrom normal cells * They are* They are recognizedrecognized andand destroyeddestroyed byby immune systemimmune system
  • 4. Etiology Of TumorEtiology Of Tumor 1) Inherited :1) Inherited : Expression of inherited oncogeneExpression of inherited oncogene e.g. viral gene incorporated into host genee.g. viral gene incorporated into host gene 2) Viral:2) Viral: - Human papilloma, herpes type 2, HBV, EBV (DNA)- Human papilloma, herpes type 2, HBV, EBV (DNA) - Human T-cell leuckemia virus (RNA)- Human T-cell leuckemia virus (RNA) 3) Chemical:3) Chemical: - Poly cyclic hydrocarbons cause sarcomas- Poly cyclic hydrocarbons cause sarcomas - Aromatic amines cause mammary carcinoma- Aromatic amines cause mammary carcinoma - Alkyl nitroso amines cause hepatoma- Alkyl nitroso amines cause hepatoma 4) Radiological:4) Radiological: Ultraviolet & ionizing irradiationUltraviolet & ionizing irradiation 5) Spontaneous:5) Spontaneous: failure in the cellular growth controlfailure in the cellular growth control
  • 5. Tumor Associated AntigensTumor Associated Antigens !) Viral Antigen :!) Viral Antigen : a- Viral proteins and glycoproteinsa- Viral proteins and glycoproteins b- New antigens produced by virally infected hostb- New antigens produced by virally infected host cells under control of viral nucleic acidcells under control of viral nucleic acid 2) Tumor specific antigens :2) Tumor specific antigens : - Tumor cells develop new antigen specific to- Tumor cells develop new antigen specific to their carcinogenstheir carcinogens 3) Tumor specific transplantation antigens :3) Tumor specific transplantation antigens : - Tumor cells express new MHC antigens due to- Tumor cells express new MHC antigens due to alteration of normally present MHC antigensalteration of normally present MHC antigens
  • 6. Tumor Associated AntigensTumor Associated Antigens 4) Oncofetal antigens:4) Oncofetal antigens: a- Carcino-embryonic antigens (CEA)a- Carcino-embryonic antigens (CEA) - Normally expressed during fetal life on fetal gut- Normally expressed during fetal life on fetal gut - Reappearance in adult life:- Reappearance in adult life: GIT, pancreas, biliary system and cancer breastGIT, pancreas, biliary system and cancer breast b- Alpha fetoprotein:b- Alpha fetoprotein: - Normally expressed in fetal life- Normally expressed in fetal life - Reappearance in adult life; hepatoma- Reappearance in adult life; hepatoma
  • 7. Immune Surveillance SystemImmune Surveillance System * During neoplastic transformation, new antigen develop* During neoplastic transformation, new antigen develop * The host recognize them as nonself antigens* The host recognize them as nonself antigens * Cell mediated immune reactions attack these* Cell mediated immune reactions attack these nonself tumor cellsnonself tumor cells * Immune response act as surveillance system* Immune response act as surveillance system to detect and eliminate newly arising neoplastic cellsto detect and eliminate newly arising neoplastic cells
  • 8. Immune Surveillance SystemImmune Surveillance System This system include :This system include : 1) Natural killer (NK) cells1) Natural killer (NK) cells They kill directly tumor cells,helped by interferon, IL-2They kill directly tumor cells,helped by interferon, IL-2 2) Cytotoxic T-cells2) Cytotoxic T-cells They also kill directly tumor cellsThey also kill directly tumor cells 3) Cell mediated T-cells (effector T-cells)3) Cell mediated T-cells (effector T-cells) They produce and release a variety of lymphokines :They produce and release a variety of lymphokines : a-Macrophage activation factora-Macrophage activation factor that activate macrophagthat activate macrophag b-Gamma interferon and interleukin-2b-Gamma interferon and interleukin-2 that activate NKthat activate NK c-Tumor necrosis factor (cachectine)c-Tumor necrosis factor (cachectine)
  • 9. Immune Surveillance SystemImmune Surveillance System 4) B-cells :4) B-cells : - Tumor associated antigens stimulate production of- Tumor associated antigens stimulate production of specific antibodies by host B-cellsspecific antibodies by host B-cells - These specific antibodies bind together on tumor cell surface- These specific antibodies bind together on tumor cell surface leading to destruction of tumor through:leading to destruction of tumor through: a- Antibody mediated-cytotoxicity :a- Antibody mediated-cytotoxicity : killkill Cytotoxic T-cells IgG-coated tumor cellsCytotoxic T-cells IgG-coated tumor cells b- Activation of macrophagesb- Activation of macrophages releaserelease Sensitized T-cells macrophage activating factorSensitized T-cells macrophage activating factor IgG-coated tumor cells macrophagesIgG-coated tumor cells macrophages activateactivate c- Activation of classical pathway of complementc- Activation of classical pathway of complement leading toleading to
  • 10. Tumor EscapeTumor Escape Mechanisms by which tumor escape immune defenses:Mechanisms by which tumor escape immune defenses: 1) Reduced levels or absence of MHCI molecule1) Reduced levels or absence of MHCI molecule onon tumor so that they can not be recognized by CTLstumor so that they can not be recognized by CTLs 2) Some tumors stop expressing the antigens2) Some tumors stop expressing the antigens These tumors are called “antigen loss variants”These tumors are called “antigen loss variants” 3) Production of immunosuppressive factors by tumor3) Production of immunosuppressive factors by tumor e.g. transforming growth factor (TGF-e.g. transforming growth factor (TGF-ββ)) 4) Tumor antigens may induce specific immunologic4) Tumor antigens may induce specific immunologic tolerancetolerance
  • 11. Tumor EscapeTumor Escape 5) Tumor cells have an inherent defect in antigen5) Tumor cells have an inherent defect in antigen processing and presentationprocessing and presentation 6) Blocking of receptors on T-cells by specific antigen6) Blocking of receptors on T-cells by specific antigen antibodies complex (antibodies complex (after shedding of tumor Ag)after shedding of tumor Ag) prevents them from recognizing and attackingprevents them from recognizing and attacking tumor cellstumor cells 7) Antigens on the surface of tumors may be masked7) Antigens on the surface of tumors may be masked by sialic acid-containing mucopolysaccharidesby sialic acid-containing mucopolysaccharides 8) Immune suppression of the host as in transplant8) Immune suppression of the host as in transplant patientspatients who show a higher incidence of malignancywho show a higher incidence of malignancy
  • 12. Tumor MarkersTumor Markers * Tumor markers :* Tumor markers : Tumor antigensTumor antigens * They are either or* They are either or Tumor productsTumor products (enzymes and hormones)(enzymes and hormones) * Tumor products are released in the serum of patients* Tumor products are released in the serum of patients * They are used to* They are used to confirm diagnosisconfirm diagnosis andand follow upfollow up thethe response toresponse to therapytherapy
  • 13. Tumor AntigensTumor Antigens 1) Alpha fetoprotein antigen (AFP)1) Alpha fetoprotein antigen (AFP) in cases of hepatomain cases of hepatoma 2) Carcinoembryoinic antigen (CEA)2) Carcinoembryoinic antigen (CEA) in gastrointestinalin gastrointestinal tumors, tumors of biliary system and cancer breasttumors, tumors of biliary system and cancer breast 3) Cancer antigen 1253) Cancer antigen 125 (CA 125)(CA 125) in ovarian carcinomain ovarian carcinoma 4) Cancer antigen 15-3 (CA15-3)4) Cancer antigen 15-3 (CA15-3) in breast cancerin breast cancer 5) Cancer antigen 19-95) Cancer antigen 19-9 in colon and pancreatic tumorin colon and pancreatic tumor 6) Prostatic specific antigen (PSA)6) Prostatic specific antigen (PSA) in prostatic tumorsin prostatic tumors
  • 14. Tumor ProductsTumor Products a) Hormones :a) Hormones : -- Human chorionic gonadotrophins (HCG)Human chorionic gonadotrophins (HCG) are secretedare secreted in cases of choriocarcinomain cases of choriocarcinoma - Thyroxin (T3 & T4)- Thyroxin (T3 & T4) is secreted in cases of canceris secreted in cases of cancer of thyroid glandof thyroid gland b) Enzymes :b) Enzymes : - Acid phosphatase- Acid phosphatase enzymes in cases of cancer prostaeenzymes in cases of cancer prostae - Alkaline phosphatese, lipase and amylase- Alkaline phosphatese, lipase and amylase enzymes inenzymes in cases of cancer pancreascases of cancer pancreas